GHK-Cu Research: What the Studies Show
Educational summary of published scientific literature. Zama Biosciences products are sold for laboratory research only and are not for human or veterinary use. Nothing on this page is medical advice or a claim about any product.
GHK-Cu is a three-amino-acid peptide bound to copper, and one of the smallest molecules in peptide research with a substantial literature. This article covers how it was discovered, why its copper binding matters, what cell and gene-expression studies report, and the limits of that evidence. For structure, molecular data and handling, see the GHK-Cu research guide.
Discovery
In 1973, Loren Pickart reported a factor in human plasma that changed the behavior of liver cells in culture. The active component turned out to be the tripeptide glycyl-L-histidyl-L-lysine (GHK). Later work showed that GHK binds copper(II) with high affinity and that the copper complex, GHK-Cu, accounts for much of its activity in cell studies. Published measurements also suggest that plasma GHK levels are higher in younger people than in older people, which drew interest in its role in extracellular-matrix biology.
Why the copper matters
Copper is needed by several enzymes involved in extracellular-matrix chemistry, such as lysyl oxidase, which cross-links collagen and elastin, and superoxide dismutase, an antioxidant enzyme. Free copper ions are reactive and can be harmful to cells. GHK binds copper tightly through its glycine and histidine residues, which makes it a model for how a small peptide can carry copper in a non-toxic form and deliver it to cells.
What the cell studies report
Most mechanistic research on GHK-Cu comes from cell culture, reviewed by Pickart (2008):
- Extracellular-matrix production. In fibroblast cultures, GHK-Cu was reported to increase synthesis of collagen, elastin and glycosaminoglycans, the main structural materials between cells.
- Matrix remodeling enzymes. It was also reported to adjust levels of metalloproteinases and their inhibitors, the enzymes that break down and rebuild the matrix.
- Cell attraction. Some studies describe GHK-Cu as a chemoattractant for certain immune and endothelial cells.
The gene-expression studies
A newer line of research used public gene-expression databases, such as the Broad Institute Connectivity Map, to see how GHK changes gene activity in human cell lines. These analyses reported that GHK shifts the expression of a large number of genes, including many linked to extracellular-matrix remodeling, antioxidant defense and DNA repair (Pickart and Margolina, 2018). These are computational analyses of existing datasets, which are useful for generating hypotheses but need confirming in direct experiments.
Limits of the evidence
- Mostly cell and animal work. Controlled human research is limited.
- Concentrated authorship. Much of the review literature comes from the discovering researcher and collaborators.
- Not approved. GHK-Cu is not an approved medicine. Research-grade GHK-Cu is a laboratory reagent.
Open research questions
- Receptor mechanism. How a tripeptide triggers such broad gene-expression changes is not fully understood.
- Copper vs peptide effects. Which effects come from copper delivery and which from GHK itself.
- Related peptides. How GHK-Cu compares with related copper peptides such as AHK-Cu.
The takeaway
GHK-Cu is a naturally occurring copper-carrying tripeptide whose cell-culture research points to extracellular-matrix and gene-expression effects. Its small size, well-defined copper binding and broad reported activity make it a popular research tool, while its mechanisms remain open questions.
Frequently asked questions
What does the research say GHK-Cu does?
Cell studies report effects on production of collagen, elastin and other matrix components, and on matrix-remodeling enzymes. Gene-expression analyses report broad changes in genes linked to extracellular-matrix remodeling and antioxidant pathways.
Where does GHK come from?
It was first isolated from human plasma in 1973. Research-grade GHK-Cu is made synthetically.
Is GHK-Cu approved?
No. It is not an approved medicine. Research-grade GHK-Cu is a laboratory reagent and is not for human use.
Related reading
Research-grade GHK-Cu is available to registered researchers. Sign in or create your researcher account →
References
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature New Biology. 1973;243(124):85–87.
- Pickart L. Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969–988.
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018;19(7):1987.
Research Use Only. This article summarizes third-party scientific literature for educational purposes. Zama Biosciences products are not drugs, supplements, cosmetics or medical devices and are not for human or veterinary use. Statements have not been evaluated by the FDA.